HSPA8 and lung adenocarcinoma: eIF3i, HSC71, MHC class I antigen, transketolase, citrate synthase, Rab-37, MLH1 and AGR2 might be putative biomarkers in HSP90 inhibition response in lung adenocarcinoma.